Abstract
Sarcopenia, characterized by progressive impairment of muscle quantity and performance, is closely linked to chronic inflammatory responses and cell death pathways. Short-chain fatty acids (SCFAs), metabolites originating from the gut microbial community, have shown immunomodulatory effects. This investigation evaluated the protective role and mechanistic basis of SCFAs in an induced sarcopenia rat model, focusing on the NF-κB signaling cascade. A pharmacologically induced sarcopenia model was established in adult female SD rats (6 months old) through bilateral ovariectomy followed by dexamethasone injections. Animals were grouped as follows: Sham, Model, and SCFAs (administered 150 mM SCFAs in drinking water for 4 weeks). Muscle function (forelimb grip strength, gastrocnemius muscle index), histological changes (H&E), reactive oxygen species, apoptosis (TUNEL), inflammatory cytokines (ELISA), gene expression (RT-qPCR), and protein expression (immunoblotting) were evaluated to assess the impact of SCFAs on sarcopenia and its underlying mechanistic basis. Relative to the Model group, SCFAs significantly increased circulating SCFA levels, improved grip strength and gastrocnemius index, restored muscle fiber structure, and reduced reactive oxygen species levels and apoptosis. SCFAs were associated with reduced NF-κB pathway activation (p-IKKβ and p-p65), downregulated NLRP3 inflammasome components (NLRP3, ASC, cleaved-Caspase-1), and reduced pyroptosis (GSDMD-N expression) and inflammatory cytokines (IL-1β and IL-18). SCFAs ameliorated sarcopenia in a pharmacologically induced rat model by suppressing NF-κB/NLRP3-mediated inflammation and pyroptosis, highlighting their potential as a candidate nutritional intervention for muscle atrophy associated with inflammation, hormonal imbalance, or metabolic stress.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
Liu, C. et al. Deciphering the obesity paradox in the elderly: A systematic review and meta-analysis of sarcopenic obesity. Obes. Rev. 24 (2), e13534 (2023).
Petermann-Rocha, F. et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle. 13 (1), 86–99 (2022).
Cheng, K. Y. K. et al. Sarcopenia and ageing, in Biochemistry and Cell Biology of Ageing: Part IV, Clinical Science. Springer. 95–120. (2023).
Ragonnaud, E. & Biragyn, A. Gut microbiota as the key controllers of healthy aging of elderly people. Immun. Ageing. 18 (1), 2 (2021).
Portincasa, P. et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int. J. Mol. Sci. 23 (3), 1105 (2022).
Mann, E. R., Lam, Y. K. & Uhlig, H. H. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat. Rev. Immunol. 24 (8), 577–595 (2024).
Frampton, J. et al. Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat. Metabolism. 2 (9), 840–848 (2020).
Liu, X. et al. Role and Mechanism of Short-Chain Fatty Acids in Skeletal Muscle Homeostasis and Exercise Performance. Nutrients, 17(9). (2025).
Sadeghi, A. et al. Curcumin ameliorates palmitate-induced inflammation in skeletal muscle cells by regulating JNK/NF-kB pathway and ROS production. Inflammopharmacology 26 (5), 1265–1272 (2018).
Thoma, A. & Lightfoot, A. P. NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. Muscle atrophy, : pp. 267–279. (2018).
Paik, S. et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol. Immunol. 18 (5), 1141–1160 (2021).
Li, Y. & Guo, B. GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets. Mol. Biomed. 6 (1), 11 (2025).
Antuña, E. et al. Inflammaging: Implications in Sarcopenia. Int. J. Mol. Sci. 23 (23), 15039 (2022).
Jimenez-Gutierrez, G. E. et al. Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update. Cells 11 (15), 2359 (2022).
Haberecht-Müller, S., Krüger, E. & Fielitz, J. Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation. Biomolecules 11 (9), 1327 (2021).
Zhang, D. et al. Short-chain fatty acids in diseases. Cell. Commun. Signal. 21 (1), 212 (2023).
Liu, Y. et al. Fiber Derived Microbial Metabolites Prevent Acute Kidney Injury Through G-Protein Coupled Receptors and HDAC Inhibition. Front. Cell. Dev. Biol. 9, 648639 (2021).
Zhou, J. et al. Pyroptosis and degenerative diseases of the elderly. Cell Death Dis. 14 (2), 94 (2023).
Wu, Y. et al. Cell pyroptosis in health and inflammatory diseases. Cell. Death Discovery. 8 (1), 191 (2022).
Liu, X. et al. Regulation of short-chain fatty acids in the immune system. Front. Immunol., Volume 14–2023. (2023).
Lian, D. et al. The Role of Oxidative Stress in Skeletal Muscle Myogenesis and Muscle Disease. Antioxidants 11 (4), 755 (2022).
Chen, X. et al. Mitochondrial dysfunction: roles in skeletal muscle atrophy. J. Translational Med. 21 (1), 503 (2023).
Funding
This study is supported by Research Project of Xinjiang Uygur Autonomous People’s Hospital (20220205).
Author information
Authors and Affiliations
Contributions
Conceptualization: HX; Methodology: ZHY, NC; Formal Analysis: ZHY, HX; Data curation: NC, HX; Writing - Original Draft: HX; Writing - Review and Editing: ZHY, NC; Funding acquisition: HX; Investigation: NC, HX; Supervision: ZHY, HX; Software: ZHY, HX; Visualization: ZHY, NC; Validation: ZHY, HX; All authors have agreed on the journal to which the article has been submitted.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
All procedures were approved by the Animal Ethics Committee of Bestcell Model Biological Center(BSMS-2024-07-31 A). The study was conducted in compliance with the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) and conducted in compliance with the institutional guidelines (Directive 2010/63/EU in Europe) for the care and use of animals.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Yu, Z., Chen, N. & Xu, H. Short-chain fatty acids alleviate sarcopenia in rats via modulation of the NF-κB signaling pathway. Sci Rep (2026). https://doi.org/10.1038/s41598-026-47873-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-47873-0
